| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |